About Advances in Pulmonary Hypertension

Publisher

Pulmonary Hypertension Association
Laura D’Anna, DrPH, Board Chair
Rino Aldrighetti, President and CEO

PHA Office

Pulmonary Hypertension Association
801 Roeder Road, Ste 1000
Silver Spring, MD 20910
301-565-3004; 301-565-3994 (fax)

Publishing Operations

Deborah L. McBride, Managing Editor
McBride Strategic Services
mcbridedeb@aol.com

ISSN 1933-088X
Copyright ©2010 by Pulmonary Hypertension Association. All rights reserved. None of the contents may be reproduced in any form whatsoever without the written permission of PHA.

Program Description

The mission of Advances in Pulmonary Hypertension is to serve as the premier forum for state of the art information regarding diagnosis, pathophysiology, and treatment of pulmonary hypertension. The 2008 Dana Point revision of the World Health Organization Classification serves as a guide to categories of pulmonary hypertension addressed in Advances in Pulmonary Hypertension. While focusing on on WHO Group I PAH, the other categories (Group II, pulmonary venous hypertension; Group III, associated with chronic lung disease and/or hypoxemia; Group IV, pulmonary embolic hypertension; Group V, miscellaneous) are also addressed. This mission is achieved by a combination of invited review articles, roundtable discussions with panels consisting of international experts in PH, and original contributions. In addition, a special section in selected issues entitled “Profiles in Pulmonary Hypertension” recognizes major contributors to the field and serves as an inspiring reminder of the rich and collegial history of dedication to advancing the field.

Objectives

• Provide up-to-date information regarding diagnosis, pathophysiology, and treatment of pulmonary hypertension.
• Serve as a forum for presentation and discussion of important issues in the field, including new paradigms of disease understanding and investigational trial design.
• Recognize and preserve the rich history of individuals who have made major contributions to the field via dedication to patient care, innovative research, and furthering the mission of the PH community to cure pulmonary hypertension.

The Scientific Leadership Council

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. Learn more about PHA's Scientific Leadership Council and associated committees.

Advances in Pulmonary Hypertension is circulated to cardiologists, pulmonologists, rheumatologists, and other selected healthcare professionals by the Pulmonary Hypertension Association. The contents of the articles are independently determined by the Editor-in-Chief and the Editorial Advisory Board.